Santa Cruz Biotechnology features a diverse variety of iGb Antibodies, specifically targeting immunoglobulin G (IgG) proteins. iGb Antibodies are extensively used in various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Immunoglobulin G plays a crucial role in the immune response, serving as the most abundant antibody in serum and facilitating the recognition and neutralization of pathogens. IgG's ability to bind to antigens and activate complement pathways makes it essential for both innate and adaptive immunity. Understanding the function and regulation of immunoglobulin G is vital for advancing therapeutic strategies and vaccine development. Researchers worldwide rely on iGb monoclonal antibodies to investigate immune system responses and pathways. The exceptional specificity of iGb monoclonal antibodies enables precise detection and analysis of immunoglobulin G in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for iGb research support scientists in their quest to advance immunological discoveries and develop innovative therapeutic approaches.